OpenLegislation

The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2003

S.R. 2003/314 · Made 20 June 2003

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

DANGEROUS DRUGS

Made 20th June 2003

Coming into operation 1st July 2003

The Department of Health, Social Services and Public Safetyf1 in exercise of the powers conferred by sections 7, 10 and 31 of the Misuse of Drugs Act 1971f2 as adapted by section 38 of that Act and now vested in itf3 and of every other power enabling it in that behalf and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act, hereby makes the following Regulations:

Annotations to the whole text

Footnotes

f1

See S.I. 1999/283 (N.I. 1) – Article 3(6)

f2

1971 c. 38

f3

S.R.O. (N.I.) 1973 No. 504; Article 5(a)

Contents

  1. 1Citation and commencement
  2. 2Interpretation
  3. 3Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002
  4. Signature
  5. Explanatory note

1Citation and commencement

These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2003 and shall come into operation on 1st July 2003.

2Interpretation

The Interpretation Act (Northern Ireland) 1954f1 shall apply to these regulations as it applies to an Act of the Northern Ireland Assembly.

3Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002

(1)

The Misuse of Drugs Regulations (Northern Ireland) 2002f1 shall be amended in accordance with paragraphs (2) to (4).

(2)

In paragraph 1 of Schedule 2 there shall be inserted –

(a)

after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and

(b)

after “Racemorphan”, “Remifentanil”.

(3)

In paragraph 1, of Part I of Schedule 4 there shall be inserted –

(a)

after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and

(b)

after “N-Ethylamphetamine”, “Zolpidem”.

(4)

In paragraph 1, of Part II of Schedule 4 there shall be inserted –

(a)

before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17 diol”; and

(b)

after “Nandrolene”, “19-Nor-4-Androstene-3, 17 dione” and “19-Nor-5-Androstene-3, 17 diol”.

Signature

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 20th June 2003.

L.S.

D. C. Gowdy

Permanent Secretary,

Department of Health, Social Services and Public Safety

Explanatory note

(This note is not part of the Regulations.)

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 by adding two substances to paragraph 1 of Schedule 2 (controlled drugs subject to the requirements of Regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27) two substances to Part I of Schedule 4 (controlled drugs subject to the requirements of Regulations 22, 23, 26 and 27) and four substances to Part II of Schedule 4 (controlled drugs expected from the prohibition on possession when in the form of a medicinal product; excluded from the application of offences arising from the prohibition on importation and exportation when imported or exported in the form of a medicinal product by any person for administration to himself; and subject to the requirements of Regulations 22, 23, 26 and 27).